Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-26-000038

Chief Technology Officer acquired 66,937 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stout Jay S Chief Technology Officer 2026-04-07 Grant or award +66,937 264,571 D
Derivatives
Stout Jay S Chief Technology Officer 2026-04-07 Grant or award · Stock Option (right to buy) +96,851 96,851 D
Loading xslF345X06/wk-form4_1775765943.xml…